2002
DOI: 10.1038/sj.leu.2402664
|View full text |Cite|
|
Sign up to set email alerts
|

P-glycoprotein as a therapeutic target: good news

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2003
2003
2020
2020

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 8 publications
0
2
0
Order By: Relevance
“…It is also worth noting that the most efficient sesquiterpenes were less toxic than verapamil toward cultured drug-sensitive cells but were specifically more toxic toward P-glycoprotein-expressing cells (data not shown). This finding is very interesting, considering that P-glycoprotein is presumably involved in malignancy of cancer cells as well as drug resistance (41) and that inhibition of P-glycoprotein by PSC-833 led to a selective direct elimination of MDR cells (42).…”
Section: Discussionmentioning
confidence: 89%
“…It is also worth noting that the most efficient sesquiterpenes were less toxic than verapamil toward cultured drug-sensitive cells but were specifically more toxic toward P-glycoprotein-expressing cells (data not shown). This finding is very interesting, considering that P-glycoprotein is presumably involved in malignancy of cancer cells as well as drug resistance (41) and that inhibition of P-glycoprotein by PSC-833 led to a selective direct elimination of MDR cells (42).…”
Section: Discussionmentioning
confidence: 89%
“…Among the various formulations of liposomal anthracyclines that have been studied and even marketed, none appears able to recruit responders outside the usual field of anthracycline activity. Finally, a very recent optimistic note is worth a mention: 132 Lehne et al 133 have shown in vivo that the simple inhibition of P-glycoprotein by valspodar may lead to the direct elimination of MDR cells perhaps because this membrane pump is also involved in malignancy as well as in drug resistance. This observation warrants further exploration, and a careful reexamination of the clinical trials already performed may shed some light upon this.…”
Section: Perspectivementioning
confidence: 99%